Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung
Walter Wang(McGill University Health Centre), David P. Carbone(Vanderbilt University), Konstantin Shilo(The Ohio State University Wexner Medical Center), Håkan Mellstedt(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Carlo M. Croce(The Ohio State University), Johan Schultz(Kancera (Sweden)), Joseph M. Amann(The Ohio State University), Alyssa Shulman(The Ohio State University)
Cited by 22
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k